-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T7IeR0QXC/WgszsOeoMzOkzgcJX5+SNoVtv0cTohOMji0kXFzH92owzdojY38lLY SzWQC+kdqXLitjvomLvxlA== 0001193125-07-024148.txt : 20070208 0001193125-07-024148.hdr.sgml : 20070208 20070208155852 ACCESSION NUMBER: 0001193125-07-024148 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070208 DATE AS OF CHANGE: 20070208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNE RESPONSE CORP CENTRAL INDEX KEY: 0000817785 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330255679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-126833 FILM NUMBER: 07592612 BUSINESS ADDRESS: STREET 1: 5931 DARWIN COURT CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7604317080 MAIL ADDRESS: STREET 1: 5931 DARWIN COURT CITY: CARLSBAD STATE: CA ZIP: 92008 424B3 1 d424b3.htm SUPPLEMENT NO. 2 TO PROSPECTUS DATED AUGUST 3, 2005 Supplement No. 2 to Prospectus Dated August 3, 2005

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-126833

THE IMMUNE RESPONSE CORPORATION

SUPPLEMENT NO. 2 TO PROSPECTUS DATED AUGUST 3, 2005

This Supplement No. 2, dated February 8, 2007, supplements certain information contained in our prospectus dated August 3, 2005 (the “Prospectus”). This supplement is not complete without, and may not be delivered or utilized except in connection with, the Prospectus, including any amendments or supplements thereto.

RECENT DEVELOPMENTS

On December 20, 2006, we effected a 1-for-100 reverse stock split of our common stock, via an amendment of our certificate of incorporation.

Corresponding adjustments were made to the exercise and conversion prices of all of our exercisable and convertible securities, and to the number of common shares issuable upon exercise/conversion thereof.

As part of the reverse stock split, we also reduced our authorized number of common shares 100-fold, from 3.5 billion to 35 million.

Our common stock is now trading under the symbol “IMRP” effective December 20, 2006 as a result of the

1-for-100 reverse stock split. Also effective on December 20, 2006, our publicly traded “Class B” warrants will trade under the symbol “IMRPZ.”

-----END PRIVACY-ENHANCED MESSAGE-----